THIAZOLDERIVATE

摘要

The present invention relates to compounds of formula (I) wherein R¹, R², R³ and R⁴ are as defined in the description and claims, and pharmaceutically acceptable salts thereof, for use as therapeutically active substances. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors, including obesity.